These findings indicate that in our small study population the ghrelin system appears not to be a major player in overweight or obesity in type 1 diabetes and that insulin treatment is likely a more important factor behind weight gain in these patients. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.